Description

Treatment algorithm for restless legs syndrome outlines the step-wise pharmacologic approach from initial dopamine agonist therapy through iron supplementation and alternative agents for refractory or augmentation cases.

More Figures from This Paper

Figure 2

In mild RLS cases, dopamine agonist therapy management after augmentation is illustrated, showing dose adjustment strategies and transition to alternative medications including alpha-2-delta ligands and opioids for resistant cases.

diagram

Figure 1

Flowchart

952 × 782px · 106.6 KB

Source Paper

Pharmacologic Treatment of Restless Legs Syndrome.

Current neuropharmacology (2021)

PMID: 33380302

DOI: 10.2174/1570159X19666201230150127

Cite This Figure

![Figure 1: Treatment algorithm for restless legs syndrome outlines the step-wise pharmacologic approach from initial dopamine agonist therapy through iron supplementation and alternative agents for refractory or augmentation cases.](https://pdfs.citedhealth.com/figures/33380302/186.png)

> Source: Qing Lv et al. "Pharmacologic Treatment of Restless Legs Syndrome.." *Current neuropharmacology*, 2021. PMID: [33380302](https://pubmed.ncbi.nlm.nih.gov/33380302/)

<figure>
  <img src="https://pdfs.citedhealth.com/figures/33380302/186.png" alt="Treatment algorithm for restless legs syndrome outlines the step-wise pharmacologic approach from initial dopamine agonist therapy through iron supplementation and alternative agents for refractory or augmentation cases." />
  <figcaption>Figure 1. Treatment algorithm for restless legs syndrome outlines the step-wise pharmacologic approach from initial dopamine agonist therapy through iron supplementation and alternative agents for refractory or augmentation cases.<br>  Source: Qing Lv et al. "Pharmacologic Treatment of Restless Legs Syndrome.." <em>Current neuropharmacology</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33380302/">33380302</a></figcaption>
</figure>

Related Evidence

Iron for Restless Leg Syndrome

Grade A · 173 studies